Brief: Lipigon Says CombiGene Terminates Licence Agreement For Lipodystrophy Project

Lipigon Pharmaceuticals AB

01/02/2024 08:58

Feb 1 (Reuters) - Lipigon Pharmaceuticals AB  LPGO.ST :
    * ANNOUNCES COMBIGENE TERMINATES LICENCE AGREEMENT FOR
LIPODYSTROPHY PROJECT
    * PROJECT, WHICH WAS OUT-LICENSED TO COMBIGENE IN 2019, WILL
RETURN TO LIPIGON BY 5 AUGUST 2024 AT THE LATEST

Source text for Eikon:  ID:nBQN64b0zv 
Further company coverage:  LPGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))